EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy

Myagmarsuren Baldan iD, Shuang Zhang, Qi Sun, Yan Su, Dong Mei, Ran Sun iD, Ao Zheng, Danni Liu, Jie Zhang, Ran Huo, Yang Tian, Le Han iD und 3 weitere

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s511655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Myagmarsuren Baldan und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: RNA, Small Interfering, Lysosomes, Photothermal Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Resistance to traditional treatments has spurred research into innovative therapeutic approaches for tumors. Among these innovative treatments, photothermal therapy (PTT) has gained increasing attention for its use of photothermal agents (PTAs) to convert light into heat for localized tumor ablation. However, PTT faces limitations due to heat shock protein 70 (HSP70)-mediated resistance in tumor cells. Combining PTT via indocyanine green (ICG) with siRNA HSP70 could reduce the thermal resistance of the tumor, thereby enhancing treatment efficacy. Albumin-based nanoparticles (NPs) can effectively deliver ICG and siRNA into tumor cells. When exposed to near-infrared (NIR) light, these nanoparticles trigger lysosomal escape and release, further enhancing gene silencing activity.

Methods

This study aimed to develop a biocompatible delivery system, HSA@ICG/siRNA NPs, for photothermal-enhanced tumor therapy. The nanoparticles were characterized for size, charge, surface functionalization, and photoconversion properties. In vitro antitumor efficacy was evaluated using MTT assay, calcein AM/PI staining, RT-PCR, and Western blot in 4T1 tumor cells. In vivo, we assessed photothermal effects, biodistribution, tumor inhibition, and biosafety following irradiation.

Results

Characterization confirmed the successful synthesis of uniform, stable HSA@ICG/siRNA NPs with effective photothermal conversion properties. Cellular uptake studies revealed high siRNA internalization, with laser-induced lysosomal escape enhancing cytoplasmic delivery. In vitro, gene silencing reduced mRNA and protein levels by 82.8% and 65%, respectively. In vivo, local tumor temperature increased to 42°C within 3 minutes, indicating a mild but effective photothermal effect. Tumor inhibition rates were 50.00% ± 9.16% for HSA@ICG and 71.26% ± 7.92% for HSA@ICG/siRNA, demonstrating enhanced tumor suppression. The treatment achieved sustained tumor targeting with minimal off-target toxicity.

Conclusion

As a dual-function photothermal therapy agent, HSA@ICG/siRNA NPs combine targeted gene silencing with photothermal effects, demonstrating significant therapeutic promise. This integrated approach addresses tumor resistance, offering a potential advancement in cancer treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingLysosomesPhotothermal TherapyAnimalsIndocyanine GreenMiceCell Line, TumorNanoparticlesFemaleInfrared RaysMice, Inbred BALB CHumansTissue DistributionHSP70 Heat-Shock ProteinsGene SilencingPhototherapy

Stichwörter der Autor:innen

HSP70 siRNAgene silencinghuman serum albuminlysosome escapephotothermal therapy

Substanzen

RNA, Small InterferingIndocyanine GreenHSP70 Heat-Shock Proteins

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Capital Medical University, Beijing, People's Republic of China.
  • Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing Laboratory of Biomedical Materials, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, People's…
  • Laboratory for Clinical Medicine, Capital Medical University, Beijing, People's Republic of China.
  • Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, People's Republic of China.
  • Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, People's Republic of China.

ORCID-Profile: Myagmarsuren Baldan, Ran Sun, Le Han, Shibo Wang

Zitieren

APA

Baldan, M., Zhang, S., Sun, Q., Su, Y., Mei, D., Sun, R., Zheng, A., Liu, D., Zhang, J., Huo, R., Tian, Y., Han, L., Wang, S., Wang, Y., & Cui, C. (2025). NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s511655

Vancouver

Baldan M, Zhang S, Sun Q, Su Y, Mei D, Sun R, et al. NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s511655

BibTeX
@article{Baldan2025,
  author = {Baldan, Myagmarsuren and Zhang, Shuang and Sun, Qi and Su, Yan and Mei, Dong and Sun, Ran and Zheng, Ao and Liu, Danni and Zhang, Jie and Huo, Ran and Tian, Yang and Han, Le and Wang, Shibo and Wang, Yaoqi and Cui, Chunying},
  title = {NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s511655}
}
Kostenlos starten →